CHIMERA Pharma is managed at a corporate level by the BIONOSTRA Group and also incorporates experienced management in the area of immunology and vaccine development:
Founder of Bionostra Group. BSc in Biological Sciences and journalist. Founder and President of Bioalma (www.bioalma.com), and Founder and President of Microbionta (www.microbionta.com) Member of the ASEBIO board of directors (Spanish Biotech Entrepreneurs Association). |
BSc in Economics. Manager of Centro Nacional de Biotecnología (Spain). Founder and General Manager of the Bionostra Group. Founder and CEO of Bioalma SL (www.bioalma.com), Founder and CEO of Microbionta SL (www.microbionta.com). |
|
PhD in Biotechnology from Surrey Univ. (UK) and researcher at Cambridge Univ. (UK). Founder of AzureBio SL. BD&L Director at OncoStem SL (Spain) and 5 year BD&L Manager at PharmaMar SL (Spain). Co-founder and R&D director of Cambridge Biostability Ltd. (UK). |
PhD at the Institute for Immunology and Virology, Univ. of Zürich and postdoctoral at Mount Sinai School of Medicine (NY) and the Centro Nacional de Biotecnología (Spain). Clinical and Molecular Virology Group Leader for 7 years at GlaxoSmithKline (UK). |
|
PhD at ETSI Agronomos Polytech. Univ. (Spain) and 3-year postdoctoral at Centro Nacional de Biotecnología (Spain) and The Samuel Roberts Noble Foundation Ardmore (US). Researcher and group leader in Bionostra group since 2000. |
PhD in inmunology and oncology at Centro Nacional de Biotecnología (Spain) and 7-year postdoctoral at Univ. of Geneva (Switzerland) and the National Institutes of Health (US). Ramon y Cajal Researcher at Centro Nacional Investig. Oncológicas (Spain). |
Santiago Gimeno de Priede - President